July 14, 2025
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of [...]
July 14, 2025
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to approximately $40 billion, with 5-7% annual growth Creates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion Increases [...]
July 11, 2025
TeraView, the pioneer and leader in terahertz technology and solutions, is pleased to announce a new collaboration with robotics leader Doolim-Yaskawa to advance multi-layer paint applications for the Korean automotive manufacturing industry. The partnership will leverage TeraView’s TeraCota 2000 terahertz system, enabling precise, non-destructive measurement and quality control of complex paint layers on vehicle bodies. [...]
ZEISS Research Award 2025 – celebrating outstanding research in optics & photonics
July 11, 2025
Prof. Dr. Jelena Vučković and Prof. Dr. Yuri Kivshar were honored with the ZEISS Research Award. Oberkochen, Munich / Germany | ZEISS Group Two renowned researchers received the ZEISS Research Award at a ceremony on Thursday evening. The award went to physicists Prof. Dr. Jelena Vučković from Stanford University and Prof. Dr. Yuri Kivshar from [...]
AAA Biotech Reveals Comprehensive Suite of Validated Antibodies & Research Reagents
July 11, 2025
Browse AAA Biotech’s new range of validated antibodies, ELISA kits, and culture media - empowering researchers with high-quality, reliable research reagents. LA JOLLA, CA, UNITED STATES -- AAA Biotech, a leader in providing validated research reagents, announces the launch of its suite of validated antibodies, ELISA kits, and culture media. The company reaffirms its commitment [...]
IDT: The Original Innovator in Gene Fragments, Leadership through Science and Quality
July 11, 2025
IDT launches all-inclusive gene fragments from 7 cents per base with 25% lower turnaround times and next-day shipping powered by its cutting-edge synthetic biology facility Global genomics solutions leader Integrated DNA Technologies (IDT), with an established reputation in scientific leadership and high-quality solutions for customers, has announced a brand-new center focused on custom genes. Driven [...]
Bio-Works Receives SEK 5.5 Million Order from Global Pharmaceutical Company
July 11, 2025
Bio-Works Technologies AB has received an order worth SEK 5.5 million from a leading global pharmaceutical company, with delivery scheduled for Q4 2025. The order covers WorkBeads™ affimAb, a chromatography resin used for antibody purification in commercial manufacturing. The customer, who has previously used WorkBeads affimAb in several commercial processes, has placed this repeat order [...]
July 10, 2025
New high-throughput format expands the SimpleCell product line, empowering researchers to run larger, more complex studies with unprecedented ease and efficiency. SAN DIEGO -- CS Genetics, a privately held genomics technology company, today announced the commercial launch of its 96-sample SimpleCell 3' Gene Expression Kit, further expanding the capabilities of its SimpleCell platform for scalable, cost-efficient [...]
July 10, 2025
Eight kit options provide full-length, paired receptor chain data for human, mouse, or hybrid samples, without the need for specialized instruments or expensive reagents. MOUNTAIN VIEW — Cellecta, Inc., a leader in functional genomics and immune profiling technologies, today announced the launch of its new DriverMap™ Single-Cell Adaptive Immune Receptor (scAIR) TCR-BCR assay product line, [...]
Advanced Instruments’ acquisition of Nova Biomedical completed
July 10, 2025
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the enterprise value has [...]

